{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:53:34Z","timestamp":1790182414437,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":32,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642281280","type":"print"},{"value":"9783642281297","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/8904_2011_118","type":"book-chapter","created":{"date-parts":[[2012,1,30]],"date-time":"2012-01-30T08:27:25Z","timestamp":1327912045000},"page":"65-72","source":"Crossref","is-referenced-by-count":40,"title":["Cardiac Pathology in Glycogen Storage Disease Type III"],"prefix":"10.1007","author":[{"given":"S. L.","family":"Austin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. D.","family":"Proia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"Spencer-Manzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Butany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. B.","family":"Wechsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. S.","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,31]]},"reference":[{"issue":"3","key":"118_CR1","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1093\/oxfordjournals.eurheartj.a015283","volume":"18","author":"H Akazawa","year":"1997","unstructured":"Akazawa H, Kuroda T et al (1997) Specific heart muscle disease associated with glycogen storage disease type III: clinical similarity to the dilated phase of hypertrophic cardiomyopathy. Eur Heart J 18(3):532\u2013533","journal-title":"Eur Heart J"},{"issue":"5","key":"118_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/01.gim.0000195896.04069.5f","volume":"8","author":"AK Ansong","year":"2006","unstructured":"Ansong AK, Li JS et al (2006) Electrocardiographic response to enzyme replacement therapy for Pompe disease. Genet Med 8(5):297\u2013301","journal-title":"Genet Med"},{"issue":"3","key":"118_CR3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI0214571","volume":"109","author":"M Arad","year":"2002","unstructured":"Arad M, Benson DW et al (2002) Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest 109(3):357\u2013362","journal-title":"J Clin Invest"},{"issue":"22","key":"118_CR4","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1161\/01.CIR.0000075270.13497.2B","volume":"107","author":"M Arad","year":"2003","unstructured":"Arad M, Moskowitz IP et al (2003) Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Circulation 107(22):2850\u20132856","journal-title":"Circulation"},{"issue":"4","key":"118_CR5","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1056\/NEJMoa033349","volume":"352","author":"M Arad","year":"2005","unstructured":"Arad M, Maron BJ et al (2005) Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 352(4):362\u2013372","journal-title":"N Engl J Med"},{"issue":"4","key":"118_CR6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ymgme.2010.07.011","volume":"101","author":"PC Barker","year":"2010","unstructured":"Barker PC, Pasquali SK et al (2010) Use of cardiac magnetic resonance imaging to evaluate cardiac structure, function and fibrosis in children with infantile Pompe disease on enzyme replacement therapy. Mol Genet Metab 101(4):332\u2013337","journal-title":"Mol Genet Metab"},{"issue":"1","key":"118_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF02265613","volume":"2","author":"S Bharati","year":"1982","unstructured":"Bharati S, Serratto M et al (1982) The conduction system in Pompe\u2019s disease. Pediatr Cardiol 2(1):25\u201332","journal-title":"Pediatr Cardiol"},{"issue":"3","key":"118_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF01744800","volume":"8","author":"JS Carvalho","year":"1993","unstructured":"Carvalho JS, Matthews EE et al (1993) Cardiomyopathy of glycogen storage disease type III. Heart Vessels 8(3):155\u2013159","journal-title":"Heart Vessels"},{"key":"118_CR9","volume-title":"Scriver\u2019s online metabolic & molecular bases of inherited disease","author":"YT Chen","year":"2009","unstructured":"Chen YT, Kishnani PS et al (2009) Glycogen storage diseases. In: Valle D, Beaudet A, Vogelstein B et al (eds) Scriver\u2019s online metabolic & molecular bases of inherited disease. McGraw-Hill, New York"},{"issue":"1","key":"118_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.transproceed.2006.10.018","volume":"39","author":"AB Cochrane","year":"2007","unstructured":"Cochrane AB, Fedson SE et al (2007) Nesiritide as bridge to multi-organ transplantation: a case report. Transplant Proc 39(1):308\u2013310","journal-title":"Transplant Proc"},{"issue":"6","key":"118_CR11","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/BF01800225","volume":"15","author":"RA Coleman","year":"1992","unstructured":"Coleman RA, Winter HS et al (1992) Glycogen debranching enzyme deficiency: long-term study of serum enzyme activities and clinical features. J Inherit Metab Dis 15(6):869\u2013881","journal-title":"J Inherit Metab Dis"},{"key":"118_CR12","doi-asserted-by":"crossref","unstructured":"Dagli AI, Zori RT et al (2009) Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet. J Inherit Metab Dis","DOI":"10.1007\/s10545-009-1088-x"},{"issue":"10","key":"118_CR13","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/clc.4960151010","volume":"15","author":"A Dritsas","year":"1992","unstructured":"Dritsas A, Sbarouni E et al (1992) QT-interval abnormalities in hypertrophic cardiomyopathy. Clin Cardiol 15(10):739\u2013742","journal-title":"Clin Cardiol"},{"issue":"5","key":"118_CR14","first-page":"622","volume":"128","author":"PC Gillette","year":"1974","unstructured":"Gillette PC, Nihill MR et al (1974) Electrophysiological mechanism of the short PR interval in Pompe disease. Am J Dis Child 128(5):622\u2013626","journal-title":"Am J Dis Child"},{"key":"118_CR15","first-page":"158","volume":"52","author":"SA Ingle","year":"2004","unstructured":"Ingle SA, Moulick ND et al (2004) Hepatocellular failure in glycogen storage disorder type 3. J Assoc Physicians India 52:158\u2013160","journal-title":"J Assoc Physicians India"},{"issue":"7","key":"118_CR16","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/GIM.0b013e3181e655b6","volume":"12","author":"PS Kishnani","year":"2010","unstructured":"Kishnani PS, Austin SL et al (2010) Glycogen storage disease type III diagnosis and management guidelines. Genet Med 12(7):446\u2013463","journal-title":"Genet Med"},{"issue":"6","key":"118_CR17","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/BF02436768","volume":"18","author":"P Lee","year":"1995","unstructured":"Lee P, Burch M et al (1995) Plasma creatine kinase and cardiomyopathy in glycogen storage disease type III. J Inherit Metab Dis 18(6):751\u2013752","journal-title":"J Inherit Metab Dis"},{"issue":"10","key":"118_CR18","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1097\/GIM.0b013e318183722f","volume":"10","author":"R McDowell","year":"2008","unstructured":"McDowell R, Li JS et al (2008) Arrhythmias in patients receiving enzyme replacement therapy for infantile Pompe disease. Genet Med 10(10):758\u2013762","journal-title":"Genet Med"},{"issue":"8","key":"118_CR19","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1136\/hrt.34.8.862","volume":"34","author":"CG Miller","year":"1972","unstructured":"Miller CG, Alleyne GA et al (1972) Gross cardiac involvement in glycogen storage disease type 3. Br Heart J 34(8):862\u2013864","journal-title":"Br Heart J"},{"issue":"7","key":"118_CR20","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1161\/01.CIR.0000050691.73932.CB","volume":"107","author":"JC Moon","year":"2003","unstructured":"Moon JC, Mundy HR et al (2003) Images in cardiovascular medicine. Myocardial fibrosis in glycogen storage disease type III. Circulation 107(7):e47","journal-title":"Circulation"},{"issue":"8","key":"118_CR21","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1007\/BF00443106","volume":"148","author":"SW Moses","year":"1989","unstructured":"Moses SW, Wanderman KL et al (1989) Cardiac involvement in glycogen storage disease type III. Eur J Pediatr 148(8):764\u2013766","journal-title":"Eur J Pediatr"},{"issue":"7","key":"118_CR22","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/0002-9149(84)90551-4","volume":"53","author":"LJ Olson","year":"1984","unstructured":"Olson LJ, Reeder GS et al (1984) Cardiac involvement in glycogen storage disease III: morphologic and biochemical characterization with endomyocardial biopsy. Am J Cardiol 53(7):980\u2013981","journal-title":"Am J Cardiol"},{"key":"118_CR23","volume-title":"Genetic and metabolic liver disease","year":"2007","unstructured":"Portmann B, Thompson R et al (eds) (2007) Genetic and metabolic liver disease. Churchill Livingstone, London"},{"issue":"1","key":"118_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0002-8703(92)90779-U","volume":"123","author":"BL Seifert","year":"1992","unstructured":"Seifert BL, Snyder MS et al (1992) Development of obstruction to ventricular outflow and impairment of inflow in glycogen storage disease of the heart: serial echocardiographic studies from birth to death at 6\u00a0months. Am Heart J 123(1):239\u2013242","journal-title":"Am Heart J"},{"issue":"1","key":"118_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0735-1097(99)00492-1","volume":"35","author":"J Shirani","year":"2000","unstructured":"Shirani J, Pick R et al (2000) Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol 35(1):36\u201344","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"118_CR26","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/ana.410110417","volume":"11","author":"AE Slonim","year":"1982","unstructured":"Slonim AE, Weisberg C et al (1982) Reversal of debrancher deficiency myopathy by the use of high-protein nutrition. Ann Neurol 11(4):420\u2013422","journal-title":"Ann Neurol"},{"issue":"6","key":"118_CR27","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0022-3476(84)80075-X","volume":"105","author":"AE Slonim","year":"1984","unstructured":"Slonim AE, Coleman RA et al (1984) Myopathy and growth failure in debrancher enzyme deficiency: improvement with high-protein nocturnal enteral therapy. J Pediatr 105(6):906\u2013911","journal-title":"J Pediatr"},{"issue":"4","key":"118_CR28","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/0002-8703(95)90097-7","volume":"130","author":"H Tada","year":"1995","unstructured":"Tada H, Kurita T et al (1995) Glycogen storage disease type III associated with ventricular tachycardia. Am Heart J 130(4):911\u2013912","journal-title":"Am Heart J"},{"issue":"3","key":"118_CR29","doi-asserted-by":"crossref","first-page":"218","DOI":"10.7326\/0003-4819-120-3-199402010-00008","volume":"120","author":"GM Talente","year":"1994","unstructured":"Talente GM, Coleman RA et al (1994) Glycogen storage disease in adults. Ann Intern Med 120(3):218\u2013226","journal-title":"Ann Intern Med"},{"issue":"7","key":"118_CR30","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/GIM.0b013e3181e0e979","volume":"12","author":"SM Vertilus","year":"2010","unstructured":"Vertilus SM, Austin SL et al (2010) Echocardiographic manifestations of Glycogen Storage Disease III: increase in wall thickness and left ventricular mass over time. Genet Med 12(7):413\u2013423","journal-title":"Genet Med"},{"issue":"1","key":"118_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3928\/01913913-20100106-08","volume":"47","author":"TL Yanovitch","year":"2010","unstructured":"Yanovitch TL, Banugaria SG et al (2010) Clinical and histologic ocular findings in Pompe disease. J Pediatr Ophthalmol Strabismus 47(1):34\u201340","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"12","key":"118_CR32","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/S0002-9149(98)00696-1","volume":"82","author":"G Yi","year":"1998","unstructured":"Yi G, Elliott P et al (1998) QT dispersion and risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy. Am J Cardiol 82(12):1514\u20131519","journal-title":"Am J Cardiol"}],"container-title":["JIMD Reports","JIMD Reports - Case and Research Reports, 2012\/3"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/8904_2011_118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T10:58:02Z","timestamp":1557485882000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/8904_2011_118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9783642281280","9783642281297"],"references-count":32,"URL":"https:\/\/doi.org\/10.1007\/8904_2011_118","relation":{},"ISSN":["2192-8304","2192-8312"],"issn-type":[{"value":"2192-8304","type":"print"},{"value":"2192-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}